IP Library › Granted Patent US 7,981,363
Granted Patent B2
US 7,981,363 · App. 11/970,952 · Granted Jul 19, 2011

System and method for analyte measurement

Assignees: Roche Diagnostics Operations, Inc.; Roche Operations Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,981,363
App. No.
11/970,952
Granted
Jul 19, 2011
Kind
B2
Abstract

A method of measuring an analyte in a biological fluid comprises applying an excitation signal having a DC component and an AC component. The AC and DC responses are measured; a corrected DC response is determined using the AC response; and a concentration of the analyte is determined based upon the corrected DC response. Other methods and devices are disclosed.

Claims (29)

1. An apparatus for determining the concentration of a medically significant component of a biological fluid, the apparatus comprising:

a cell for receiving a sample of the fluid, the cell supporting:

a chemistry which reacts with the medically significant component; and

first and second terminals across which the reaction of the chemistry with the medically significant component can be assessed;

wherein at least a portion of said chemistry is in contact with said first and second terminals;

an instrument having:

first and second terminals complementary to the first and second terminals, respectively, of the cell;

wherein placement of the first and second terminals of the cell in contact with the first and second terminals, respectively, of the instrument permits the instrument to assess the reaction; and

an assessment controller for:

applying across the first and second terminals of the instrument a first signal;

determining a first correction value in response of the cell to the first signal, wherein the determining a first correction value step comprises:

determining a frequency response of the cell to the first signal;

comparing the frequency response of the cell to a stored frequency response characteristic of a specific interferent to determine an interferent concentration; and

determining the first correction value based upon the interferent concentration;

assessing the reaction of the medically significant component with the chemistry; and

combining the correction value with the result of the reaction assessment to produce an indication of the concentration of the medically significant component of the sample;

wherein the first signal comprises a signal having an AC component.

2. The apparatus of claim 1 , wherein:

the biological fluid comprises blood;

the medically significant component comprises glucose; and

said chemistry comprises a chemistry which reacts with the glucose in the blood.

3. The apparatus of claim 2 , wherein the first correction value comprises an indicated glucose-to-actual glucose correction factor.

4. The apparatus of claim 1 , wherein the first signal comprises an AC signal.

5. The apparatus of claim 1 , wherein:

the biological fluid comprises blood;

the medically significant component comprises glucose;

the interferent comprises hematocrit; and

said chemistry comprises a chemistry which reacts with the glucose in the blood.

6. The apparatus of claim 5 , wherein the first correction value comprises an indicated glucose-to-actual glucose correction factor.

Assignments (6)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Apr 24, 2024
From: ROCHE OPERATIONS LTD.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 067204/0694 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 23, 2015
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: ROCHE DIABETES CARE, INC.
Reel/Frame 036008/0670 →
CHANGE OF NAME Recorded May 5, 2009
From: CORANGE INTERNATIONAL LIMITED
To: ROCHE OPERATIONS LTD.
Reel/Frame 022634/0371 →
CORRECTIVE ASSIGNMENT TO CORRECT THE ASSIGNMENT OF ASSIGNOR'S INTEREST PREVIOUSLY RECORDED ON REEL 022153 FRAME 0373. ASSIGNOR(S) HEREBY CONFIRMS THE ASSIGNMENT TO CORANGE INTERNATIONAL LIMITED OF AN UNDIVIDED ONE-HALF INTEREST. Recorded Mar 25, 2009
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: CORANGE INTERNATIONAL LIMITED
Reel/Frame 022445/0886 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 26, 2009
From: ROCHE DIAGNOSTICS OPERATIONS, INC.
To: CORANGE INTERNATIONAL LIMITED
Reel/Frame 022153/0373 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Feb 13, 2008
From: BURKE, DAVID W.; KUHN, LANCE S.; BEATY, TERRY A.; SVETNIK, VLADIMIR
To: ROCHE DIAGNOSTICS OPERATIONS, INC.
Reel/Frame 020503/0553 →
Continuity (7)
Continuation 11376858 · Mar 16, 2006
Division 10687668 · Oct 17, 2003
Continuation In Part 10264890 · Oct 4, 2002
Division 09530171
Continuation In Part 08996280 · Dec 22, 1997
Provisional Application 60480298 · Jun 20, 2003
Related Publication 20080098802A1 · May 1, 2008